The international surgical journal with global reach

Multinational, double-blind, randomised, placebo controlled, prospective study of esomeprazole in the prevention of recurrent peptic ulcer in low-dose acetylsalicylic acid users: the LAVENDER study. Gut 2014; 63: 1061-1068.

Published: 13th November 2014

Authors: Sugano K, Choi M-G, Lin J-T, Goto S, Okada Y, Kinoshita Y et al. et al.

Conclusion

Some 364 patients with a history of peptic ulcer, and taking aspirin for cardioprotection were included. Esomeprazole improved the rate of freedom from re-ulceration at 48 weeks from 81.2 to 98.3 per cent.

Pubmed Link